Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Löwenberg B . Acute myeloid leukemia: the challenge of capturing disease variety. Hematology Am Soc Hematol Educ Program 2008; 2008: 1–11.

    Article  Google Scholar 

  2. Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 2011; 17: 1086–1093.

    Article  CAS  Google Scholar 

  3. Bartel DP . Micrornas: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.

    Article  CAS  Google Scholar 

  4. Chen C-Z, Li L, Lodish HF, Bartel DP . Micrornas modulate hematopoietic lineage differentiation. Science 2004; 303: 83–86.

    Article  CAS  Google Scholar 

  5. Gocek E, Wang X, Liu X, Liu C-G, Studzinski GP . Microrna-32 upregulation by 1,25-dihydroxyvitamin d3 in human myeloid leukemia cells leads to bim targeting and inhibition of arac-induced apoptosis. Cancer Res 2011; 71: 6230–6239.

    Article  CAS  Google Scholar 

  6. Han YC, Park CY, Bhagat G, Zhang J, Wang Y, Fan JB et al. Microrna-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med 2010; 207: 475–489.

    Article  CAS  Google Scholar 

  7. Bousquet M, Harris MH, Zhou B, Lodish HF . Microrna mir-125b causes leukemia. Proc Natl Acad Sci USA 2010; 107: 21558–21563.

    Article  CAS  Google Scholar 

  8. O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J et al. Sustained expression of microrna-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008; 205: 585–594.

    Article  CAS  Google Scholar 

  9. Marcucci G, Maharry KS, Metzeler KH, Volinia S, Wu YZ, Mrózek K et al. Clinical role of micrornas in cytogenetically normal acute myeloid leukemia: mir-155 upregulation independently identifies high-risk patients. J Clin Oncol 2013; 31: 2086–2093.

    Article  CAS  Google Scholar 

  10. de Leeuw DC, Denkers F, Olthof MC, Rutten AP, Pouwels W, Schuurhuis GJ et al. Attenuation of microrna-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res 2014; 74: 2094–2105.

    Article  CAS  Google Scholar 

  11. Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059–2074.

    Article  Google Scholar 

  12. Feller N, van der Pol MA, van Stijn A, Weijers GW, Westra AH, Evertse BW et al. MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia. Leukemia 2004; 18: 1380–1390.

    Article  CAS  Google Scholar 

  13. Terwijn M, van Putten WL, Kelder A, van der Velden VH, Brooimans RA, Pabst T et al. High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the hovon/sakk aml 42a study. J Clin Oncol 2013; 31: 3889–3897.

    Article  Google Scholar 

  14. Silva FP, Swagemakers SM, Erpelinck-Verschueren C, Wouters BJ, Delwel R, Vrieling H et al. Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by runx1 mutation status. Blood 2009; 114: 3001–3007.

    Article  CAS  Google Scholar 

  15. Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 2014; 506: 328–333.

    Article  CAS  Google Scholar 

  16. Xu X, Wells A, Padilla MT, Kato K, Kim KC, Lin Y . A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance. Carcinogenesis 2014; 35: 2457–2466.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Part of this research was financed by a grant (08-0075) from World Wide Cancer Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Smit.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Leeuw, D., Verhagen, H., Denkers, F. et al. MicroRNA-551b is highly expressed in hematopoietic stem cells and a biomarker for relapse and poor prognosis in acute myeloid leukemia. Leukemia 30, 742–746 (2016). https://doi.org/10.1038/leu.2015.160

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2015.160

This article is cited by

Search

Quick links